Zacks Research Lowers Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Zacks Research lowered their Q3 2025 earnings estimates for shares of Henry Schein in a report issued on Thursday, October 17th. Zacks Research analyst R. Department now anticipates that the company will earn $1.35 per share for the quarter, down from their prior forecast of $1.36. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s FY2025 earnings at $5.19 EPS, Q3 2026 earnings at $1.39 EPS and FY2026 earnings at $5.67 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. Henry Schein’s revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.31 EPS.

Other analysts have also recently issued research reports about the stock. UBS Group dropped their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Price Performance

Shares of HSIC stock opened at $71.67 on Friday. Henry Schein has a 12 month low of $60.01 and a 12 month high of $82.63. The stock has a 50-day moving average price of $70.26 and a 200 day moving average price of $69.90. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.18 billion, a price-to-earnings ratio of 24.21, a PEG ratio of 1.98 and a beta of 0.86.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Swedbank AB bought a new stake in Henry Schein in the 1st quarter valued at approximately $215,998,000. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein in the second quarter worth $46,683,000. SG Americas Securities LLC boosted its holdings in Henry Schein by 1,622.3% during the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after purchasing an additional 432,187 shares during the last quarter. Nuance Investments LLC grew its position in Henry Schein by 28.5% in the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after purchasing an additional 388,843 shares in the last quarter. Finally, Magnetar Financial LLC increased its stake in Henry Schein by 229.9% in the 1st quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock valued at $29,185,000 after buying an additional 269,330 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.